Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study on Genomic and Methylation Signatures in Patients with Extensive-Stage Small Cell Lung Cancer and Metastatic Large Cell Neuroendocrine Carcinoma Undergoing Chemo-Immunotherapy

NCT06717243 is registered in ClinicalTrials.gov with Oncology Center of Biochemical Education And Research as lead sponsor.

NCT NCT06717243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06717243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study on Genomic and Methylation Signatures in Patients with Extensive-Stage Small Cell Lung Cancer and Metastatic Large Cell Neuroendocrine Carcinoma Undergoing Chemo-Immunotherapy
Lead sponsor
Oncology Center of Biochemical Education And Research
Phase
Observational
Overall status
Recruiting
Start date
February 20, 2025
Completion date
December 1, 2028
Enrollment
111 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

biomarkers, biomarkers / blood, immunotherapy, large cell neuroendocrine (ne) tumors, small cell lung cancer, treatment failure